Cargando…
Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
BACKGROUND: Subclinical LV dysfunction (LVD) identifies heart failure (HF) risk in type 2 diabetes mellitus (T2DM). We sought the extent to which clinical scores (ARIC-HF, WATCH-DM), natriuretic peptides (NTpBNP) and troponin (hs-TnT) were associated with subclinical LV dysfunction (LVD). These asso...
Autores principales: | Halabi, Amera, Potter, Elizabeth, Yang, Hilda, Wright, Leah, Sacre, Julian W., Shaw, Jonathan E., Marwick, Thomas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737699/ https://www.ncbi.nlm.nih.gov/pubmed/36494683 http://dx.doi.org/10.1186/s12933-022-01711-5 |
Ejemplares similares
-
Associations of subclinical heart failure and atrial fibrillation with mild cognitive impairment: a cross-sectional study in a subclinical heart failure screening programme
por: Potter, Elizabeth L, et al.
Publicado: (2021) -
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
por: Mochizuki, Yasuhide, et al.
Publicado: (2015) -
Variations in subclinical left ventricular dysfunction, functional capacity, and clinical outcomes in different heart failure aetiologies
por: Wang, Ying, et al.
Publicado: (2018) -
Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Nicol, Martin, et al.
Publicado: (2019) -
Subclinical left ventricular dysfunction in COVID-19
por: Bhatia, Harpreet S., et al.
Publicado: (2021)